Literature DB >> 6715042

Biological activities of synthetic lipid A analogs: pyrogenicity, lethal toxicity, anticomplement activity, and induction of gelation of Limulus amoebocyte lysate.

K Tanamoto, U Zähringer, G R McKenzie, C Galanos, E T Rietschel, O Lüderitz, S Kusumoto, T Shiba.   

Abstract

Chemically synthesized lipid A analogs were investigated for several endotoxic activities, including pyrogenicity, lethal toxicity, anticomplement activity, and the capacity to gelate Limulus amoebocyte lysate in comparison to natural lipid A. The synthetic preparations contained D-glucosamine or D-glucosamine-beta-1,6-D-glucosamine disaccharide substituted by ester- and amide-bound hydroxylated or non-hydroxylated fatty acids and by phosphate groups in different combinations. Some preparations which were insoluble in water were succinylated and thus rendered more soluble. Strong biphasic pyrogenic responses with a maximal increase in body temperature of 1 to 2 degrees C were obtained with 50 micrograms/kg doses of 3 disaccharide preparations of 15 tested. With two preparations (50 micrograms/kg) moderate pyrogenicity with monophasic fever curves and a maximal temperature increase of about 0.6 degrees C was obtained. Lethal toxicity tests were carried out in galactosamine-sensitized mice. Of 15 synthetic preparations, 4 exhibited lethal toxicity under these conditions. The effective doses of the lipid A analogs in both in vivo tests were, however, several hundred times higher than those of bacterial lipid A. For the activities in vivo, hydroxyacyl residues seemed to be important. Anticomplement activity was demonstrable in seven preparations, one of which expressed an activity comparable to that of lipid A. Preparations containing non-hydroxylated fatty acids seemed to be most active in this test. None of the synthetic preparations was found to exhibit gelation activity for Limulus amoebocyte lysate when tested in doses up to 0.4 micrograms, whereas bacterial free lipid A was active in doses of about 2 pg. None of the monosaccharide derivatives exhibited any of these activities.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6715042      PMCID: PMC263535          DOI: 10.1128/iai.44.2.421-426.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Differences of chemical structures of Pseudomonas aeruginosa lipopolysaccharide essential for adjuvanticity and antitumor and interferon-inducing activities.

Authors:  Y Cho; K Tanamoto; Y Oh; J Y Homma
Journal:  FEBS Lett       Date:  1979-09-01       Impact factor: 4.124

2.  The role of the physical state of lipopolysaccharides in the interaction with complement. High molecular weight as prerequisite for the expression of anti-complementary activity.

Authors:  C Galanos; O Lüderitz
Journal:  Eur J Biochem       Date:  1976-06-01

3.  Picogram-sensitive assay for endotoxin: gelation of Limulus polyphemus blood cell lysate induced by purified lipopolysaccharides and lipid A from Gram-negative bacteria.

Authors:  E T Yin; C Galanos; S Kinsky; R A Bradshaw; S Wessler; O Lüderitz; M E Sarmiento
Journal:  Biochim Biophys Acta       Date:  1972-01-28

4.  Biological activities of chemically modified endotoxins.

Authors:  E T Rietschel; C Galanos; A Tanaka; E Ruschmann; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1971-09-24

5.  The enhancement of antibody formation by Escherichia coli lipopolysaccharide and detoxified derivatives.

Authors:  J R Schenck; M P Hargie; M S Brown; D S Ebert; A L Yoo; F C McIntire
Journal:  J Immunol       Date:  1969-06       Impact factor: 5.422

6.  Electrodialysis of lipopolysaccharides and their conversion to uniform salt forms.

Authors:  C Galanos; O Lüderitz
Journal:  Eur J Biochem       Date:  1975-06

7.  Chemical structure and biological activities of lipid A's from various bacterial families.

Authors:  O Lüderitz; C Galanos; V Lehmann; H Mayer; E T Rietschel; J Weckesser
Journal:  Naturwissenschaften       Date:  1978-11

8.  Preparation and properties of antisera against the lipid-A component of bacterial lipopolysaccharides.

Authors:  C Galanos; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1971-12-22

9.  Regions of the lipopolysaccharide of Pseudomonas aeruginosa essential for antitumor and interferon-inducing activities.

Authors:  K Tanamoto; C Abe; J Y Homma; Y Kojima
Journal:  Eur J Biochem       Date:  1979-07

10.  Lipid A antiserum-mediated protection against lipopolysaccharide- and lipid A-induced fever and skin necrosis.

Authors:  E T Rietschel; C Galanos
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

View more
  23 in total

1.  Tumor necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice.

Authors:  M A Freudenberg; C Galanos
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  Specific detection of Haemophilus influenzae type b lipooligosaccharide by immunoassay.

Authors:  J Mertsola; R S Munford; O Ramilo; X Sáez-Llorens; M M Mustafa; G H McCracken; E J Hansen
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

3.  Natural phosphoryl and acyl variants of lipid A from Neisseria meningitidis strain 89I differentially induce tumor necrosis factor-alpha in human monocytes.

Authors:  Constance M John; Mingfeng Liu; Gary A Jarvis
Journal:  J Biol Chem       Date:  2009-06-15       Impact factor: 5.157

4.  Somnogenic activities of synthetic lipid A.

Authors:  A B Cady; S Kotani; T Shiba; S Kusumoto; J M Krueger
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

Review 5.  The role of lipopeptidophosphoglycan in the immune response to Entamoeba histolytica.

Authors:  Isabel Wong-Baeza; Marcela Alcántara-Hernández; Ismael Mancilla-Herrera; Itzmel Ramírez-Saldívar; Lourdes Arriaga-Pizano; Eduardo Ferat-Osorio; Constantino López-Macías; Armando Isibasi
Journal:  J Biomed Biotechnol       Date:  2010-01-21

6.  Transitions in oral and intestinal microflora composition and innate immune receptor-dependent stimulation during mouse development.

Authors:  Mizuho Hasegawa; Toshifumi Osaka; Kazuki Tawaratsumida; Takashi Yamazaki; Hiroyuki Tada; Grace Y Chen; Satoshi Tsuneda; Gabriel Núñez; Naohiro Inohara
Journal:  Infect Immun       Date:  2009-11-23       Impact factor: 3.441

7.  Endotoxic induction of prostaglandin release from macrophages by nontoxic lipid A analogs synthesized chemically.

Authors:  K Tanamoto; U Shade; E T Rietschel; S Kusumuto; T Shiba
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

8.  Lipid X ameliorates pulmonary hypertension and protects sheep from death due to endotoxin.

Authors:  D T Golenbock; J A Will; C R Raetz; R A Proctor
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

9.  Free hydroxyl groups are not required for endotoxic activity of lipid A.

Authors:  K Tanamoto
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

10.  Mitogenic activities of synthetic lipid A analogs and suppression of mitogenicity of lipid A.

Authors:  K Tanamoto; C Galanos; O Lüderitz; S Kusumoto; T Shiba
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.